Gelder Mark S. MD has filed 5 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 62000 shares of Traws Pharma, Inc. ($TRAW) on March 13, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2023 | Traws Pharma, Inc. | $TRAW | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | A | Stock Option (right to purchase) | 62000 | $0.00 | 62,000.0000 | 20,908,235 | 9999.99% | 0.30% |
| March 13, 2023 | Traws Pharma, Inc. | $TRAW | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 20667 | $0.00 | 20,667.0000 | 20,908,235 | 9999.99% | 0.10% |
| Feb. 7, 2023 | Traws Pharma, Inc. | $TRAW | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | M | Common Stock | 5833 | $0.00 | 11,729.0000 | 20,908,235 | 98.93% | 0.03% |
| Feb. 7, 2023 | Traws Pharma, Inc. | $TRAW | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | F | Common Stock | 1242 | $1.36 | 10,487.0000 | 20,908,235 | 10.59% | 0.01% |
| Feb. 7, 2023 | Traws Pharma, Inc. | $TRAW | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 5833 | $0.00 | 11,667.0000 | 20,908,235 | 33.33% | 0.03% |